ArticleMagma (New York, N.Y.)2026
Gadobenate dimeglumine-enhanced MRI at hepatobiliary phase can predict liver regeneration after partial hepatectomy in fibrotic rats.
Article in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveLiver regeneration after partial hepatectomy (PH) is markedly impaired in liver fibrosis, leading to serious complications. Non-invasive imaging methods for predicting regenerative capacity are crucial for preoperative planning and risk assessment. Gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI at hepatobiliary phase has recently shown promise for assessing liver function. This study investigated the predictive value of Gd-BOPTA-enhanced MRI at hepatobiliary phase for liver regeneration in fibrotic rats. MATERIALS AND
methodsThirty male Sprague-Dawley rats with experimentally induced liver fibrosis underwent Gd-BOPTA-enhanced MRI. The relative enhancement ratios of liver parenchyma (REL) and biliary system (REB) were quantified during the hepatobiliary phase. After 70% PH, the liver regeneration rate (LRR) was calculated on day 3 and 5. Stepwise multivariable linear regression was conducted to identify imaging and biochemical determinants of LRR.
resultsIn fibrotic rats, the mean LRRs were 0.80 ± 0.10 (range, 0.64-1.01) and 1.06 ± 0.09 (range, 0.89-1.17) on day 3 and 5 after PH, respectively. Multivariable analysis identified REL (p = 0.002), REB (p = 0.026), and alanine aminotransferase (ALT; p = 0.040) as the strongest determinants of LRR on day 3 (Predicted LRR on day 3 = 0.368 + 1.332 × REL + 0.105 × REB - 0.001 × ALT(IU/l)). On day 5, REL (p < 0.001) and REB (p = 0.023) remained significant determinants of LRR (Predicted LRR on day 5 = 1.107 + 2.601 × REL - 0.173 × REB). DISCUSSION: Gd-BOPTA-enhanced MRI at hepatobiliary phase can effectively predict LRR on day 3 and 5 after partial hepatectomy in fibrotic rats.
Indexed as
Identifiers
41557079What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.